| Dr Christopher Lanski, PT, DPT, MBA | |
|
203 S. Daisy Street, Salmon, ID 83467 | |
| (208) 756-5600 | |
| Not Available |
| Full Name | Dr Christopher Lanski |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 203 S. Daisy Street, Salmon, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497045447 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2538 (Nevada) | Secondary |
| 225100000X | Physical Therapist | PT-8988 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Lanski, PT, DPT, MBA 203 S. Daisy Street, Salmon, ID 83467 Ph: (208) 756-5600 | Dr Christopher Lanski, PT, DPT, MBA 203 S. Daisy Street, Salmon, ID 83467 Ph: (208) 756-5600 |
News Archive
After a major review of scientific information, six leading tobacco research and policy experts have concluded that a nicotine reduction strategy should be an urgent research priority because of its potential to profoundly reduce the death and disease from tobacco use. Their findings were published today in the journal Tobacco Control.
Did Obama say enough about health care reform last night? I suppose I'm one of the very few people who would even ask that question. Most Americans would probably think, "More health care? Lord no." And I think Obama and his speechwriters sensed as much. Although his defense of the Affordable Care Act was clear - he's not going to sign a bill repealing the law - it was also short. That portion of the speech was just two brief paragraphs, by my count (Jonathan Cohn, 1/26).
Bio-Optronics and Clinical Research Associates (CRA) have developed a strategic relationship to provide a turn-key solution for a clinical research site's patient recruitment needs, which couples Bio-Optronics' Clinical Conductor™ Clinical Trial Management System (CTMS) and Clinical Research Associates' patient recruitment offerings.
Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, today announced that it has achieved positive safety and tolerability results in the first clinical study of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure. Each year in the United States, more than one million patients are hospitalized with acute heart failure.
› Verified 7 days ago
Alpenglow Physio Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 S Center St, Salmon, ID 83467 Phone: 617-620-5534 | |
Kathryn Blackadar Oldham, P.T., DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 802 Shoup St, Salmon, ID 83467 Phone: 208-756-2005 Fax: 208-756-4020 | |
Ms. Cynthia Grier, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 203 S Daisy St, Salmon, ID 83467 Phone: 208-756-5631 | |
Nancy J Bryant, P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 802 Shoup St, Salmon, ID 83467 Phone: 208-756-2005 Fax: 208-756-4020 | |
Kylie Spotts, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 802 Shoup St, Salmon, ID 83467 Phone: 208-756-2005 Fax: 208-756-4020 | |
Dr. Annah Benedict Dahle, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: Porgy & Petunia's Pediatric Therapy 111 E Lillian, Suite 8, Salmon, ID 83467 Phone: 208-940-2170 Fax: 208-756-2354 |